{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["2ff7780b-7fb2-4698-8e8a-e03df0e6827e", "YY", 24772, "MEDICAL ADVOCACY SERVICES", 132531, "AMERICAN COLLEGE OF RHEUMATOLOGY", 2003, "year_end", "2004-02-05T00:00:00-05:00", 60000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/2ff7780b-7fb2-4698-8e8a-e03df0e6827e/\", \"filing_uuid\": \"2ff7780b-7fb2-4698-8e8a-e03df0e6827e\", \"filing_type\": \"YY\", \"filing_type_display\": \"Year-End Report\", \"filing_year\": 2003, \"filing_period\": \"year_end\", \"filing_period_display\": \"Year-End (July 1 - Dec 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/2ff7780b-7fb2-4698-8e8a-e03df0e6827e/print/\", \"filing_document_content_type\": \"application/pdf\", \"income\": \"60000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": null, \"dt_posted\": \"2004-02-05T00:00:00-05:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": \"United States of America\", \"registrant_address_1\": null, \"registrant_address_2\": null, \"registrant_different_address\": null, \"registrant_city\": null, \"registrant_state\": null, \"registrant_zip\": null, \"registrant\": {\"id\": 24772, \"url\": \"https://lda.senate.gov/api/v1/registrants/24772/\", \"house_registrant_id\": 31278, \"name\": \"MEDICAL ADVOCACY SERVICES\", \"description\": null, \"address_1\": \"2011 PENNSYLVANIA AVE NW   #800\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"WASHINGTON\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20006\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"\", \"contact_telephone\": \"\", \"dt_updated\": \"2022-01-13T14:49:21.563739-05:00\"}, \"client\": {\"id\": 132531, \"url\": \"https://lda.senate.gov/api/v1/clients/132531/\", \"client_id\": 24, \"name\": \"AMERICAN COLLEGE OF RHEUMATOLOGY\", \"general_description\": null, \"client_government_entity\": null, \"client_self_select\": null, \"state\": null, \"state_display\": null, \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"1996-02-14\"}, \"lobbying_activities\": [{\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"CMS's rulemaking on the Medicare fee schedule.\\r\\nCMS's effort to reform the AWP Methodology for Part B covered drugs.\", \"foreign_entity_issues\": null, \"lobbyists\": [{\"lobbyist\": {\"id\": 2311, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"JENNIFER\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BRUNELLE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"N/A\", \"new\": null}, {\"lobbyist\": {\"id\": 29503, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ROB\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BLASER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"N/A\", \"new\": null}, {\"lobbyist\": {\"id\": 30510, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"THARINI\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SATHIAMOORTHY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"N/A\", \"new\": null}], \"government_entities\": [{\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Appropriations for Veterans Administration,AHRQ,NIH,CDC.\\r\\nIssues related to proposed reform of the A.W.P. drug pricing methodology.\\r\\nS.1/H.R.1 - Prescription Drug and Medicare Act of 2003.\\r\\nS.11 - Patients First Act of 2003\\r\\n\", \"foreign_entity_issues\": null, \"lobbyists\": [{\"lobbyist\": {\"id\": 2311, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"JENNIFER\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BRUNELLE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"N/A\", \"new\": null}, {\"lobbyist\": {\"id\": 29503, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ROB\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BLASER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"N/A\", \"new\": null}, {\"lobbyist\": {\"id\": 30510, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"THARINI\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SATHIAMOORTHY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"N/A\", \"new\": null}], \"government_entities\": [{\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["2ff7780b-7fb2-4698-8e8a-e03df0e6827e"], "units": {}, "query_ms": 80.70554514415562, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}